Comprehensive multi‐omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single‐center, open‐label, single‐arm phase II trial

Yuzhou Zhao(Capital Medical University), Ying Liu(Zhengzhou University), Chunmiao Xu(Zhengzhou University), Rongrong Zheng, Chenxuan Liu(Henan Cancer Hospital), Qingxin Xia(Zhengzhou University), Chengjuan Zhang(Zhengzhou University), Xuan Gao(Tsinghua University), Jinbang Wang(Dalian National Laboratory for Clean Energy), Chen-Yu Liu(Institute on Governance), Zhi Li(Central Hospital Affiliated to Shenyang Medical College), Yong Zhang(Zhengzhou University), Sen Li(Xi'an Jiaotong University), Ke Li(Xi'an University of Science and Technology), Pengfei Ma(First Affiliated Hospital of Zhengzhou University), Lei Qiao(State Key Laboratory for Innovation and Transformation of Luobing Theory), Du Wang(Jiangsu Hengrui Medicine (China)), Juan Yu(Southern Medical University), Jinwang Wei(GenomiCare (China)), Zhimeng Li(Zhengzhou University), Zhentian Liu, Shuning Xu(Zhengzhou University), Yanghui Cao(Zhengzhou University), Jing Zhuang(Zhengzhou University), Danyang Li(Henan University of Technology), Zhiguo Hou(Jiangsu Hengrui Medicine (China))
Clinical and Translational Medicine
April 29, 2024
Cited by 22


Related Papers